• / Free eNewsletters & Magazine
  • / My Account
Home>Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®

Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®

3party Content

Tue, 5 May 2015

- Expects to be eligible for 180 days of marketing exclusivity -POTTERS BAR, England and PITTSBURGH, May 5, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today confirmed that it and its subsidiaries Mylan Pharmaceuticals Inc. and Mylan Technologies Inc. have been sued by Noven Pharmaceuticals Inc.
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.